# RhythmScience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rhythmscience

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.rhythm360.io
- Total disclosed funding: $6M
- Latest round: Series A (Mar 23, 2023)
- Investors on record: 3

## About

Based in California, US, and founded in 2019 by CEO Shawn Kumar, RhythmScience Inc., a.k.a. RhythmScience operates as a health-tech company that is developing virtual cardiac care pipelines to improve the management of hypertension, heart failure, and rhythm management. In March 2023, RhythmScience raised USD 6 million in a Series A funding led by Cedars-Sinai Health System, with participation from OCA Ventures and TenOneTen Ventures.

The company provides a Rhythm360 platform that analyzes cardiac data from tens of thousands of patients and creates standardized data that reduce missed diagnoses and helps avoid unnecessary hospitalizations. The platform offers a single-source solution to track all cardiac implants and wearables, blood pressure cuffs, and weight scales in one integrated portal.

RhythmScience plans to use its proceeds from March 2023 funding for the development of an innovative cardiology data platform that offers providers a complete data system across hypertension, heart failure, and rhythm disorders.

## Funding rounds

- Series A, Mar 23, 2023, $6M — OCA Ventures, TenOneTen Ventures, Cedars-Sinai Health System

## Investors

- OCA Ventures (https://capitalatlas.ai/funds/oca-ventures) — Series A
- TenOneTen Ventures (https://capitalatlas.ai/funds/tenoneten-ventures) — Series A
- Cedars-Sinai Health System — Series A